BCAT-IN-4
Product Specifications
UNSPSC Description
BCAT-IN-4 (Compound 1) is a BCAT inhibitor. BCAT-IN-4 exhibits a moderate ability to inhibit hBCATc with IC50 value of 2.35 μM. BCAT-IN-4 can be used for the research of neurodegenerative diseases[1].
Target Antigen
Others
Type
Reference compound
Related Pathways
Others
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/bcat-in-4.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC2=C(OC3=C2C=CC=C3)C=C1)NNS(=O)(C4=CC=CC=C4)=O
Molecular Weight
366.39
References & Citations
[1]Hu LY, et al. The design and synthesis of human branched-chain amino acid aminotransferase inhibitors for treatment of neurodegenerative diseases. Bioorg Med Chem Lett. 2006 May 1;16(9):2337-40.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-153878/BCAT-IN-4-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-153878/
Clinical Information
No Development Reported
CAS Number
406190-85-0
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MP1302J Each
Magic™ Membrane Protein Human MOG (Myelin oligodendrocyte glycoprotein) expressed in E.coli for Antibody Discovery
Ask
View Details ![Rabbit Monoclonal F4/80 Antibody (Cl:A3-1 (recombinant version)) [DyLight 594]](https://cdn.genprice.uk/genprice/genprice4.png)
NBP2-81029DL594 0.1 mL
Rabbit Monoclonal F4/80 Antibody (Cl:A3-1 (recombinant version)) [DyLight 594]
Ask
View Details